Riskpilot← Back to searchSign inGet full accessAB Miratek Sweden
ABActiveOrg 5593627051Trestegsvägen 8Medical specialists activities · NACE 8622Est. 20220 employees
Revenue 2025
SEK 618K
-59% vs 2024
EBITDA margin
9.2%
-92% vs 2024
Equity ratio
24.5%
Financial strength
Net profit 2025
SEK 46K
-92% vs 2024
| Revenue | SEK 618K | -59% |
| EBITDA | SEK 57K | -92% |
| Net profit | SEK 46K | -92% |
| Total assets | SEK 350K | -69% |
| Equity | SEK 86K | -85% |
| Employees | 0 | — |
Legal name
AB Miratek Sweden
Org number
5593627051
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 januari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet och specialistkompetens inom psykiatri sluten och öppenvård samt därmed förenlig verksamhet
Address
Trestegsvägen 8
Email
mira.carmaciu@miratek.org
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 204 | 914 | 1 519 | 618 |
| Staff expenses | — | −690 | −757 | −517 |
| EBITDA | 202 | 164 | 707 | 57 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 202 | 164 | 707 | 57 |
| Net financials | — | −0 | 0 | 1 |
| Profit before tax | 202 | 129 | 708 | 58 |
| Tax | −42 | −27 | −146 | −12 |
| Net profit | 161 | 102 | 562 | 46 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 275 | 506 | 1 144 | 350 |
| Equity | 186 | 128 | 590 | 86 |
| Long-term debt | — | — | — | — |
| Short-term debt | 89 | 343 | 520 | 230 |
| Total debt | 89 | 343 | 520 | 230 |
EBITDA margin
9.2%
This company
15.8%
Market median
-42% vs market
20222025
Equity ratio
24.5%
This company
38.2%
Market median
-36% vs market
20222025
Return on equity
53.7%
This company
18.4%
Market median
+192% vs market
20222025
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20222025
Asset turnover
1.76×
This company
1.12×
Market median
+57% vs market
20222025
Debt / equity
3.09×
This company
0.62×
Market median
-398% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-27 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Miratek Sweden also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mihai Milea Carmaciu | Deputy Board Member | 0 companies |
| Patrik Carl Johannes Tavassoli | Board of Directors | 0 companies |
| Iulia Mira Milea Carmaciu | Board of Directors | 0 companies |
| Jens Gunnar Rosenblad | Deputy Board Member | 0 companies |